Gossamer Bio GOSS
NASDAQ GOSS
$11.01 +0.36 (+3.38%)
As of: Nov 10, 2026 · 3:20 PM EST

Gossamer Bio (GOSS) Net Long-Term Debt Issued (Repaid) (2018 - 2024)

Updated

Gossamer Bio (GOSS) posted Net Long-Term Debt Issued (Repaid) of -$12.58 million for FY2024, compared with -$11.61 million in FY2023.

Analysis

Gossamer Bio (GOSS) Net Long-Term Debt Issued (Repaid) (2018 - 2024) Analysis & Trends

Since FY2017, Gossamer Bio has reported Net Long-Term Debt Issued (Repaid) for 7 years.

  • The FY2024 figure stands as the lowest annual Net Long-Term Debt Issued (Repaid) in data going back to FY2017.
  • Business Quant data shows GOSS's Net Long-Term Debt Issued (Repaid) at -$11.61 million in FY2023, -$5.81 million in FY2022 and $193.6 million in FY2020 (+586.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Gossamer Bio 45.16 Mn -428.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -9.68 Mn
Mar 31, 2024 -2.90 Mn
Dec 31, 2023 -2.90 Mn
Sep 30, 2023 -2.90 Mn
Jun 30, 2023 -2.90 Mn
Mar 31, 2023 -2.90 Mn
Dec 31, 2022 -2.90 Mn
Sep 30, 2022 -2.90 Mn
Mar 31, 2018 -40,000.00
API Access

Gossamer Bio Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=GOSS&period=max&api_key=YOUR_API_KEY